Intimate Partner Violence (IPV)NCT01942616
The Development of a Domestic Violence Perpetrator Collusion Measurement Tool
A study testing Condition 1: Perpetrator Positive and Condition 2: Perpetrator Negative in people with Intimate Partner Violence (IPV), run by Yale University at 4 sites in United States.
Trial summary
We propose an experimental design to empirically establish the potential link between the media portrayal of DV and changes in an individual's DV descriptive and injunctive social norms. Specifically, this study will measure the degree to which people implicitly collude with DV perpetration. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Intimate Partner Violence (IPV)
- What is being tested?
- Condition 1: Perpetrator Positive and Condition 2: Perpetrator Negative
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 72 participants
- Where
- 4 sitesUnited States
- Study dates
- Jul 2009to Jan 2010
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Members of the public who are 18 years or older, who identify as White or African American or Hispanic.
Who cannot join
- Members of the public will be excluded if they are unable to read or understand English.
Trial locations and contacts
4 sites in 1 country.
United States4 sites
Michigan State University
East Lansing, Michigan, 48824
Michigan Department of Community Health
Lansing, Michigan, 48913
Yale University
New Haven, Connecticut, 06519
Loyola University New Orleans
New Orleans, Louisiana, 70118
About this study
Official title: Media, Public Health, and Colluding With Murder: The Development of a Domestic Violence Perpetrator Collusion Measurement Tool.
We propose an experimental design to empirically establish the potential link between the media portrayal of DV and changes in an individual's DV descriptive and injunctive social norms. Specifically, this study will measure the degree to which people implicitly collude with DV perpetration.
Read the detailed description
Aim 1: To determine the impact of media "frames," "labeling," and "information inclusion" on "implicit collusion" with a DV perpetrator.
Hypotheses: Consumers exposed to media reports using "thematic frames" will be less likely to implicitly collude with perpetrators than those exposed to "episodic frames." Consumers exposed to DVH news stories labeled as "domestic violence" will be less likely to implicitly collude with perpetrators than consumers exposed to news stories labeled as "assault." Implicit collusion will correlate positively with the addition of non-relevant perpetrator "humanizing" characteristics. Consumers given negative information about the victim of DVH will be more likely to implicitly collude with the perpetrator than consumers given negative information about the perpetrator.
Aim 2: To determine how media portrayals of domestic violence impact descriptive and injunctive norms about domestic violence and, ultimately, drive implicit collusion with perpetrators.
Hypotheses: Controlling for individual pre-existing attitudes and social norms, consumers exposed to thematic frames or the label of DV will be less likely to shift their norms in a way that supports DV than those exposed to episodic frames or the label of assault. Consumers provided negative victim information or non-relevant characteristics that humanize the perpetrator will be more likely to shift their norms to accept DV.
Exploratory Aim: To identify racial/ethnic, gender, age, and regional differences in DV social norms.
Hypothesis: The media will differentially impact subpopulation DV attitudes, social norms and implicit collusion.
- Conditions
- Intimate Partner Violence (IPV)
- Being tested
- Condition 1: Perpetrator Positive, Condition 2: Perpetrator Negative, Condition 3: Placebo
- Keywords
- IPV
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Condition 1: Perpetrator PositiveOther
Condition 1 frames the event as episodic, labels the event as domestic violence, uses a positive description of the perpetrator, and a negative description of the victim.
Condition 2: Perpetrator NegativeOther
The condition 2 intervention/exposure frames the event as thematic, labels the event as assault, uses a neutral description of the perpetrator, and a negative description of the perpetrator.
Condition 3: PlaceboOther
This intervention provides no details for the participant and is for comparison use in the study.
| Study group | Role | What they receive |
|---|---|---|
| Condition 1 | Experimental | Each study arm contains different scenarios presented to the participant.
Condition 1 is a Perpetrator Positive scenario.
The content of the Condition 1 group is as follows:
Framing: Episodic Labeling: DV label Extraneous Information: Perpetrator positive non relevant Victim/Perp Characteristic: Negative victim Receives: Other: Condition 1: Perpetrator Positive |
| Condition 2 | Experimental | Each study arm contains different scenarios presented to the participant.
Condition 2 is a Perpetrator Negative scenario.
The content of the Condition 2 group is as follows:
Framing: Thematic Labeling: Assault label Extraneous Information: Perpetrator neutral non relevant Victim/Perp Characteristic: Negative Perpetrator Receives: Other: Condition 2: Perpetrator Negative |
| Condition 3 | Placebo comparator | Each study arm contains different scenarios presented to the participant.
The content of the Condition 3 group is as follows:
Framing: Neither Labeling: No label Extraneous Information: None Victim/Perp Characteristic: None Receives: Other: Condition 3: Placebo |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from Baseline on The Collusion Framing Subscale
The scale will be developed based on the changes from baseline.
Measured: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
Change from Baseline on The Collusion Labeling Subscale
The scale will be developed based on the changes from baseline.
Measured: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
Change from Baseline on The Collusion Extraneous Information Subscale
The scale will be developed based on the changes from baseline.
Measured: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
Change from Baseline on The Collusion Negative Characteristics Subscale
The scale will be developed based on the changes from baseline.
Measured: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Sep 2013 (estimated)
- Study startJul 2009
- Primary completionJan 2010
- Study completionJan 2010
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Intimate Partner Violence (IPV)Studies of the same condition, open and under way.
- More trials run by Yale UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 72 participants (actual)
Sponsor and investigators
- Lead sponsor
- Yale University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01942616
- Sponsor's protocol ID
- 0910005885
- Status last verified
- Aug 2023
- First submitted
- 30 Aug 2013
- Last updated
- 30 Aug 2023
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Aug 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Media, Public Health, and Colluding With Murder: The Development of a Domestic Violence Perpetrator Collusion Measurement Tool.
- ClinicalTrials.gov ID
- NCT01942616
- Acronym / sponsor ID
- 0910005885
- Conditions
- Intimate Partner Violence (IPV)
- Keywords
- IPV
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 72 participants (actual)
- Lead sponsor
- Yale UniversityUniversity, hospital or other
- Study start
- Jul 2009
- Primary completion
- Jan 2010 (actual)
- Study completion
- Jan 2010 (actual)
- First posted
- 16 Sep 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
We propose an experimental design to empirically establish the potential link between the media portrayal of DV and changes in an individual's DV descriptive and injunctive social norms. Specifically, this study will measure the degree to which people implicitly collude with DV perpetration.
Detailed description
Aim 1: To determine the impact of media "frames," "labeling," and "information inclusion" on "implicit collusion" with a DV perpetrator.
Hypotheses: Consumers exposed to media reports using "thematic frames" will be less likely to implicitly collude with perpetrators than those exposed to "episodic frames." Consumers exposed to DVH news stories labeled as "domestic violence" will be less likely to implicitly collude with perpetrators than consumers exposed to news stories labeled as "assault." Implicit collusion will correlate positively with the addition of non-relevant perpetrator "humanizing" characteristics. Consumers given negative information about the victim of DVH will be more likely to implicitly collude with the perpetrator than consumers given negative information about the perpetrator.
Aim 2: To determine how media portrayals of domestic violence impact descriptive and injunctive norms about domestic violence and, ultimately, drive implicit collusion with perpetrators.
Hypotheses: Controlling for individual pre-existing attitudes and social norms, consumers exposed to thematic frames or the label of DV will be less likely to shift their norms in a way that supports DV than those exposed to episodic frames or the label of assault. Consumers provided negative victim information or non-relevant characteristics that humanize the perpetrator will be more likely to shift their norms to accept DV.
Exploratory Aim: To identify racial/ethnic, gender, age, and regional differences in DV social norms.
Hypothesis: The media will differentially impact subpopulation DV attitudes, social norms and implicit collusion.
Study design
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind (participant)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Condition 1 | Experimental | Other: Condition 1: Perpetrator PositiveEach study arm contains different scenarios presented to the participant. Condition 1 is a Perpetrator Positive scenario. The content of the Condition 1 group is as follows: Framing: Episodic Labeling: DV label Extraneous Information: Perpetrator positive non relevant Victim/Perp Characteristic: Negative victim |
| Condition 2 | Experimental | Other: Condition 2: Perpetrator NegativeEach study arm contains different scenarios presented to the participant. Condition 2 is a Perpetrator Negative scenario. The content of the Condition 2 group is as follows: Framing: Thematic Labeling: Assault label Extraneous Information: Perpetrator neutral non relevant Victim/Perp Characteristic: Negative Perpetrator |
| Condition 3 | Placebo comparator | Other: Condition 3: PlaceboEach study arm contains different scenarios presented to the participant. The content of the Condition 3 group is as follows: Framing: Neither Labeling: No label Extraneous Information: None Victim/Perp Characteristic: None |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Members of the public who are 18 years or older, who identify as White or African American or Hispanic.
Key exclusion criteria (1 listed)
- Members of the public will be excluded if they are unable to read or understand English.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Condition 1: Perpetrator PositiveCondition 1 frames the event as episodic, labels the event as domestic violence, uses a positive description of the perpetrator, and a negative description of the victim. | Other | Condition 1 |
| Condition 2: Perpetrator NegativeThe condition 2 intervention/exposure frames the event as thematic, labels the event as assault, uses a neutral description of the perpetrator, and a negative description of the perpetrator. | Other | Condition 2 |
| Condition 3: PlaceboThis intervention provides no details for the participant and is for comparison use in the study. | Other | Condition 3 |
Primary outcome
Change from Baseline on The Collusion Framing Subscale
Time frame: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
The scale will be developed based on the changes from baseline.
Change from Baseline on The Collusion Labeling Subscale
Time frame: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
The scale will be developed based on the changes from baseline.
Change from Baseline on The Collusion Extraneous Information Subscale
Time frame: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
The scale will be developed based on the changes from baseline.
Change from Baseline on The Collusion Negative Characteristics Subscale
Time frame: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.
The scale will be developed based on the changes from baseline.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Aug 2023.
Related trials for Intimate Partner Violence (IPV)
Recruiting
Adjunctive Motivational Alcohol Intervention to Prevent IPV
Alcohol Use and Intimate Partner Violence
Recruiting
SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Families
Substance Abuse, Intimate Partner Violence (IPV)
Recruiting
RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV
Intimate Partner Violence (IPV)
Active, not recruiting
Multi-component Family Intervention to Lower Depression and Address Intimate Partner Violence in Nepal
Intimate Partner Violence (IPV), Depression
Not yet recruitingPhase 2
Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence
Post Traumatic Stress Disorder PTSD, Intimate Partner Violence (IPV)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
4 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Condition 1: Perpetrator Positive and Condition 2: Perpetrator Negative in people with Intimate Partner Violence (IPV), run by Yale University at 4 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 4 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from Baseline on The Collusion Framing Subscale (time frame: The scale is administered at baseline and then following the sub experiment for a total of 2 times, 30 minutes apart.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Aug 2023.